The Uncomfortable Truth About Ozempic

TL;DR

GLP-1 drugs like Ozempic eliminate obesity more effectively than any diet, but long-term dependency may be required to maintain results.

Key Points

• 1.Semaglutide and tirzepatide (Ozempic/Mounjaro) work by mimicking the GLP-1 hormone, suppressing appetite 24/7 for up to a week per dose, making users lose 20%+ of body weight — matching bariatric surgery results.
• 2.Health benefits go beyond weight loss: 20% reduced stroke/heart attack risk, 66% lower diabetes development odds, plus improvements in sleep apnea, kidney/liver function, and potentially Alzheimer's and fertility.
• 3.GLP-1 drugs may also reduce addiction to alcohol, nicotine, cannabis, and opioids — large trials are currently underway to confirm this unprecedented effect.
• 4.The main risks are muscle loss from rapid weight loss (requiring protein and resistance training), plus minor side effects (nausea, diarrhea) and rare serious issues like pancreatitis in under 5% of users.
• 5.The uncomfortable truth: ~20% of users regain all lost weight after stopping, meaning millions may need lifelong use — though current evidence suggests staying on the drug is still far healthier than remaining obese.